S
chool attendance is associated with academic success. 1 Early detection of children at high risk of frequent school absenteeism may allow for interventions to increase the likelihood of school completion. 2 Children with chronic illness have an increased risk of absenteeism and lower academic achievement compared with children in general. 3, 4 School attendance in chronically ill children is associated with disease severity, disease control, physical limitations, psychological factors, and parental perception of their child's health. 5 School absenteeism is not well described in the pediatric chronic kidney disease (CKD) population. Pediatric CKD has unique impacts on growth and development that potentially may affect school attendance beyond what is seen in other chronic diseases. Up to 25% of children <5 years of age with CKD have developmental delays, 6 and children with CKD are more likely to have lower academic achievement scores and lower IQ scores than their siblings. 7 Children with CKDassociated urologic abnormalities often have bowel/bladder incontinence and may require bladder catheterization, which can be challenging for school-aged children. 8, 9 The purpose of this study was to characterize chronic school absenteeism among children in the US with mild-to-moderate CKD and to compare the prevalence with published norms among healthy American children. In addition, we sought to identify predictors of chronic school absenteeism in children with CKD, recognizing that identification of these factors is an important first step in developing interventions to address barriers to school attendance.
Methods
This study is an analysis of baseline data obtained from children participating in the Chronic Kidney Disease in Children (CKiD) multicenter cohort study, with data supplied by the National Institutes of Diabetes and Digestive and Kidney Diseases Central Repositories. All participating sites in the CKiD study have local institutional review board approval, and additional institutional review board approval was obtained from our institution for the current analyses using deidentified data. The study enrolls children between 1 and 16 years of age with mild-to-moderate CKD (glomerular filtration rate [GFR] of 30-90 mL/min/1.73 m 2 ) from >50 sites across the US. A more complete description of the CKiD study design and protocol has been published previously. 10 The present study was limited to children ≥6 years of age at the time of study enrollment (n = 667). Age <6 years was an exclusion criterion, given that children <6 years of age are not enrolled routinely in school programs. A total of 608 children were included in the final analyses, after the exclusion of 28 children who did not attend school outside their home and 31 children with missing school absenteeism data.
Exposures
Exposure variables were selected from the baseline CKiD study visit to account for both demographic and clinical characteristics that could potentially influence absenteeism. Age was categorized as <11 years, 11-14 years, and >14 years of age to approximate elementary, middle, and high school. Type of insurance (private vs public) and maternal education (high school or less, some college, or college graduate) were included as socioeconomic indicators. IQ was calculated from the Wechsler Abbreviated Scale of Intelligence. Scores were reported on a numeric scale between 0 and 200. The mean Wechsler Abbreviated Scale of Intelligence score is 100 (SD 15 points).
CKD-specific factors including estimated glomerular filtration rate (eGFR), type of CKD, and urologic complications were evaluated. Severity of CKD was defined by an eGFR ≥60 mL/min/1.73 m 2 or <60 mL/min/1.73 m 2 , based on the bedside Schwartz equation. 11 Type of CKD was categorized as glomerular or nonglomerular disease. Urologic data were collected from the caregiver report to determine whether the child 
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had enuresis and/or required bladder catheterization. Determination of anemia and hyperphosphatemia was based on Kidney Disease Improving Global Outcomes age-specific guidelines. 12, 13 Hypertension was determined based on caregiver report. Height z-scores of −2 or less were used to identify short stature, in accordance with the Kidney Disease Improving Global Outcomes definition of short stature. 13 The number of medications taken by each participant was used to assess medication burden. Medication burden was categorized as 1-4 medications, 5-9 medications, and ≥10 medications. We also evaluated the association between frequency of medication administration and school absenteeism. To capture the impact of acute illnesses on school absenteeism, data on urinary tract infection (UTI), hospitalizations, and emergency department visits in the last year also were collected. These data were based on parental/caregiver report and were evaluated in a separate analysis, given the ambiguous temporality with respect to school absenteeism during the previous year.
Outcome
School attendance in the CKiD study was based on caregiver/ parent recall, by asking "During the past school year, approximately how many days has (name of child) missed from school because of not feeling well?" The answer was recorded as the number of days missed. Children were categorized as "chronically absent" if ≥18 days of school were missed in the last year. This decision was made to align with other published school absenteeism data.
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Statistical Analyses
Stata, version 12.0 (StataCorp LLC, College Station, Texas) was used for all analyses. The proportion of children with ≥18 days of school missed in the last year was reported. To compare the proportion of children with CKD and chronic school absenteeism with the proportion of children studied in National Health and Nutrition Examination Survey with chronic absenteeism, a c 2 test was used. We estimated relative risks (RRs) and 95% confidence intervals (CIs) to evaluate which variables were predictive of chronic school absenteeism in our CKD study population. Because our primary focus was prediction, not etiology, our main analyses assessed the relationship of each demographic and clinical factors to chronic school absenteeism. We also evaluated potential confounding by all demographic and clinical variables. Only those variables that individually changed our risk estimate by at least 10% were accounted for with Mantel-Haenszel adjustment. Where confounding was present, both crude and adjusted risk estimates were reported.
RRs and 95% CIs also were estimated to evaluate the relationship between chronic school absenteeism and the presence of acute illnesses (UTI, hospitalization, and emergency department visits) during the previous year. The timing of days missed relative to the exposures was not available, so we were unable to determine whether a given day of absenteeism occurred during the illness or hospitalization. Despite this limitation, we adjusted for the occurrence of hospitalization in one analysis of the association between the occurrence of UTIs and chronic absenteeism. Mean IQ scores and SD were calculated for each absenteeism group.
Results
The overall prevalence of chronic school absenteeism among children with CKD was 17.3% (n = 105), in contrast to 2.7% of children in the National Health and Nutrition Examination Survey population (RR 6.2, 95% CI 4.6-8.4). Characteristics of children with CKD in whom chronic absenteeism was and was not present are presented in Table I .
Univariate analyses of the associations between demographic and CKD-specific variables and chronic school absenteeism are presented in Table II . Neither age nor race/ ethnicity was related to chronic school absenteeism. Boys experienced less chronic absenteeism than girls (RR 0.65, 95% CI 0.46-0.91). Among children with CKD whose mother obtained a college degree, the risk of chronic school absenteeism was 0.52 times that of children whose mother obtained a high school degree or less (95% CI 0.33-0.83). Mean IQ score in the chronic absenteeism group was 94.5 (95% CI 91.2-97.7) and 97.4 (95% CI 95.9-99.0) in the group without chronic school absenteeism. There was little association between severity of CKD and chronic school absenteeism. Glomerular CKD was associated with more chronic school absenteeism than nonglomerular CKD (RR 1.6, 95% CI 1.1-2.2).
The risk of chronic school absenteeism was greater among participants with urologic issues, specifically enuresis or the need for bladder catheterization. Both variables had a substantial amount of missing data (24% among the chronic absenteeism group, 35% among children without chronic absenteeism). The risk of chronic absenteeism was 60% greater among participants with documented enuresis (95% CI 1.0-2.4). When adjusted for type of CKD, the risk of chronic school absenteeism was 2.2 times greater among children requiring bladder catheterization (95% CI 1.4-3.7). Given the elevated risk of UTI in children with enuresis or bladder catheterization, we repeated this analysis with adjustment for the presence of UTI in the last year. This adjustment attenuated both risk estimates, with an adjusted RR of 1.5 for enuresis (95% CI 0.98-2.3) and an adjusted RR of 1.6 for bladder catheterization (95% CI 0.84-3.2).
There was a strong relationship between greater medication burden and chronic school absenteeism. When compared with a baseline category of 1-4 medications, children requiring 5-9 medications had 2.3 times the risk of chronic school absenteeism (95% CI 1.6-3.4), and children requiring ≥10 medications had 4.2 times the risk (95% CI 2.6-6.7). To evaluate whether medication burden was a marker of disease severity, the relationship between medication burden and chronic school absenteeism was adjusted for GFR category, but this did not appreciably alter risk estimates. Children requiring medication administration at least twice per day were 2.6 times as likely to be chronically absent from school compared with those requiring once per day dosing (95% CI 2.4-5.1). There was no stepwise increase in absenteeism as THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 199 • August 2018 medication frequency increased beyond twice per day. Adjustment for frequency of medication administration had only a modest effect on the relationship between medication burden and chronic absenteeism. A history of acute illness also was associated positively with chronic school absenteeism. Study participants with at least 1 UTI in the last year had an increased risk of chronic school absenteeism compared with those with no such infections. This relationship remained present after adjusting for a history of hospitalization in the last year, to account for any effect from hospitalization for diagnosis and/or treatment of the infection (RR 2.5, 95% CI 1.6-3.8). A history of hospitalization (any reason) within the last year was associated with a 4.1 times greater risk of chronic school absenteeism (95% CI 2.9-5.8). Children with CKD who had 1 visit to the emergency department in the last year also demonstrated an increased risk of chronic school absenteeism (RR 2.9, 95% CI 1.7-4.9); the corresponding RR among children with >1 visit to the emergency department was 5.8 (95% CI 3.8-8.7). All variables have <5% missing data unless otherwise noted. *Numbers may not add up to total due to missing data. †50% missing data in each group. ‡Variable has 24% missing data in chronic absenteeism group and 35% missing data in group without chronic absenteeism. §Pill burden represents the number of unique medications reported by participant/caregiver; 2.9% missing data in group with chronic school absenteeism, 7.8% missing data in group without chronic school absenteeism. August 2018
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Children with CKD were found to have a greater frequency of chronic school absenteeism than children in the US in general. As pediatric providers, we counsel families on the longterm impacts of chronic illness, but influences on education commonly are not discussed. 15, 16 Educational outcomes in adults with childhood-onset CKD are poor, 17 and chronic absenteeism is likely contributing to lower achievement. In addition, school attendance is linked closely to social functioning in children, with school absenteeism potentially characterizing children with a lower quality of life. 3, 5 We identified several predictors of school absenteeism among children with CKD, including demographic, socioeconomic, and disease-specific indicators. Although these exposures and characteristics are not necessarily modifiable or causal, they may permit the identification of relatively high-risk children. Conversely, greater maternal education was associated with a lower risk of chronic school absenteeism. The reduced risk associated with a greater level of maternal education is similar to the association of maternal education with other childhood health outcomes and may serve as a surrogate indicator of socioeconomic status.
There was no association between chronic school absenteeism and eGFR, possibly because eGFR may not fully capture the overall burden of disease. Some of the factors associated with chronic school absenteeism that we identified are related to disease control (such as medication burden) and/or the occurrence of acute illnesses. These findings are similar to studies in other chronic disease populations, such as children with asthma and lupus, where school absenteeism has been associated with poor disease control. 18, 19 Asthma literature suggests the association between absenteeism and the intensity of disease management may be useful not only to identify children at risk for school failure but to identify children with suboptimal disease control based on the number of missed school days. 18, 20 If causal, the association between medication burden and chronic school absenteeism suggests a potentially modifiable exposure. Medication burden is not only a surrogate of disease severity, it likely is an indicator of relatively poor disease control as well. Previous studies have shown that complex pill regimens are associated with lower levels of medication adherence. 21, 22 Regardless of the mechanism driving the association between medication burden and absenteeism, it can be used as an identifier of patients at particularly high risk for chronic school absenteeism.
This study of school absenteeism in the CKD population provides insight into the scope of the problem among patients with CKD. Although the frequency of chronic school absenteeism is striking in the CKD population, these findings are likely an underestimate. The method of outcome ascertainment in this study likely underrepresents the true burden of chronic illness on school attendance, as it does not capture partial missed days for clinic appointments and does not account for time out of the classroom for school nurse visits, medication administration, or catheterization. Future study should target longitudinal assessment of absenteeism in children with CKD to avoid the temporality issues raised by this cross-sectional assessment.
Healthcare providers may have a limited view of patients' lives outside of the hospital or clinic setting. Asking about school attendance provides insight into how children and families are coping with chronic illness and is something many patients and caregivers want to discuss. 15 Enhanced communication between educators and clinicians could allow for a shared understanding of how to support children with complex healthcare needs. [23] [24] [25] Healthcare providers also need to better understand school resources and parental concerns regarding the school's ability to recognize and manage a medical issue during the school day. 20 As healthcare teams, we need to understand barriers to school attendance to develop appropriate targeted interventions to help children attend school and succeed in the classroom. 
